Company

NFlection Therapeutics

Biotechnology Research Boston, Ma, United States 9 employees

Employees: 9
Contacts: 1
Emails: 1
Phones: 1

www.nflection.com LinkedIn Crunchbase

NFlection Therapeutics Overview

Headquarters: Boston, Ma, United States
Website: www.nflection.com
Industry: Biotechnology Research
Employees: 9
Funding: 20.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Wheaton

About NFlection Therapeutics

NFlection is a biopharmaceutical company focused on the development of novel therapies to address the needs of patients with neurofibromatosis type 1, immunosuppressant-mediated squamous cell carcinoma, and congenital birthmarks such as keratinocytic epidermal nevi. To address these RAS-mediated disorders, driven by the aberrant activation of the Ras/Raf/MEK/ERK pathway, we are developing first-in-class MEK (mitogen-activated protein kinase kinase) inhibitors as topical treatments.

NFlection Therapeutics Contact Details

People in AeroLeads: 2
With contact data: 1
Email contacts: 1; 50.0% coverage
Phone contacts: 1; 50.0% coverage

NFlection Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Scott Plotkin	Mass General Neuro-oncologist, Harvard		View
William Hodder	Chief Executive Officer at Nflection	San Diego County, California, United States	Email Phone